ImpactRx

ImpactRx, Inc. has named Richard C. Altus president and chief executive officer. Mr. Altus served as president and acting chief executive officer since May of this year. Per Lofberg, chairman of ImpactRx’s board of directors and president of Merck Capital Ventures, an investor in ImpactRx, stated, “During his first six months on the job, Rich has proven to be an effective leader and has continued to build on the company’s successes. He has established a clear strategic direction for the company and has made real progress in ensuring that the organization executes its business objectives. This action by the board to fully endorse him as president and chief executive officer is confirmation of our confidence in Rich’s ability to lead ImpactRx into the future.”

Mr. Altus, who joined the company in 2002, has more than 25 years of financial and management experience in both private and public companies. Prior to his current position, he was the company’s chief financial officer. Before joining the company, he served as chief operating officer for Medical Broadcasting Company, a company that was an innovator in the use of online and e-marketing techniques for the pharmaceutical and biotechnology industries.